• Profile
Close

Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero

Annals of Rheumatic Diseases Apr 18, 2019

Mofors J, et al. - Authors researched data from 119 subjects with congenital heart block (CHB) and their 128 siblings to investigate comorbidity and outcomes in subjects with CHB and their siblings. They found a significantly increased risk of cardiovascular comorbidity among people with CHB, with cardiomyopathy and/or heart failure observed in 20 (16.8%) patients vs 3 (0.3%) controls. An inclined risk of infections was also noticed in subjects with CHB. An association of pacemaker treatment with a decreased risk of cerebral infarction but increased risks of cardiomyopathy/heart failure and infection was also reported. An increased risk to develop any of 15 common autoimmune conditions was noticed in both patients with CHB and their siblings. They also recorded a higher risk of systemic connective tissue disorder in patients with CHB.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay